Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.99 USD | +12.23% | +3.69% | +54.20% |
13/05 | Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target | MT |
13/05 | TScan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.20% | 514M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+48.04% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- TCRX Stock
- News TScan Therapeutics, Inc.
- Sector Update: Health Care Stocks Mixed Premarket Tuesday